The Advantages of Not Arguing With Someone Who Has Dementia

“Where’s my college ring?” This had become Dad’s mantra during some months of his early demented years. I knew he hadn’t gotten...


The post The Advantages of Not Arguing With Someone Who Has Dementia appeared first on Minding Our Elders.
             

Related Stories



* What People Living with Dementia Would Like Their Caregivers to Understand
* Family Worries about Memory Care Staffing and Lack of Training
* Happy Mother’s Day to all Who Care for Others!


 


http://dlvr.it/TSXGkG

This daily habit could lower dementia risk by 35%, scientists say

A huge long-term study found that drinking two to three cups of coffee a day was linked to a much lower risk of dementia, especially before age 75. Researchers say caffeine may help keep brain cells active while reducing inflammation and harmful plaque buildup associated with Alzheimer’s disease. But more coffee wasn’t better — the protective effect appeared to level off after moderate intake.


http://dlvr.it/TSWwpn

This daily habit could lower dementia risk by 35%, scientists say

A huge long-term study found that drinking two to three cups of coffee a day was linked to a much lower risk of dementia, especially before age 75. Researchers say caffeine may help keep brain cells active while reducing inflammation and harmful plaque buildup associated with Alzheimer’s disease. But more coffee wasn’t better — the protective effect appeared to level off after moderate intake.


http://dlvr.it/TSWnKY

Dawn Mertineit, Marcus Mintz, and Michael Wexler Author Chapter on US Trade Secrets Trends in Chambers Global Practice Guide

Dawn Mertineit, Marcus Mintz, and Michael Wexler, co-chairs of Seyfarth’s national Trade Secrets, Computer Fraud, and Non-Competes practice, are among the contributing authors to the Chambers Trade Secrets 2026 Global Practice Guide. Mertineit, Mintz, and Wexler authored Chapter 13, “USA Trends and Developments,” examining the evolving US legal landscape governing restrictive covenants, trade secret protection, and employee mobility. The chapter provides... Continue Reading


http://dlvr.it/TSWm3y

Forget daily pills. This shot works when blood pressure meds fail

A twice-yearly injection may soon change how high blood pressure is treated. In a global trial, patients receiving the experimental drug zilebesiran alongside standard therapy saw greater blood pressure reductions than those on standard treatment alone. The drug works by blocking a key liver protein, helping blood vessels relax. Researchers say this long-lasting approach could make it much easier for patients to keep their condition under control.


http://dlvr.it/TSWKNl